852715-69-6Relevant articles and documents
Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones
Ferlin, Maria Grazia,Chiarelotto, Gianfranco,Gasparotto, Venusia,Dalla Via, Lisa,Pezzi, Vincenzo,Barzon, Luisa,Palu, Giorgio,Castagliuolo, Ignazio
, p. 3417 - 3427 (2007/10/03)
In our search for potential new anticancer drugs, we designed and synthesized a series of tricyclic compounds containing the antimitotic 2-phenylazaflavone chromophore fused to a pyrrole ring in a pyrroloquinoline structure. Compounds 8, 18, 19, 22, 23, 25 and 26, when tested against a panel of fourteen human tumor cell lines, showed poor in vitro cytotoxic activity, whereas 20, 21 and 24 showed significant activity (IC50 0.7 to 50 μM). Steroid hormone-sensitive ovary, liver, breast and adrenal gland adenocarcinoma cell lines displayed the highest sensitivity (IC50 0.7 to 8 μM). Compound 24 blocked cells in the G2/M phase of the cell cycle and induced a significant increase in apoptotis. Compounds 20, 21 and 24 proved to alter microtubule assembly and stability, displaying a cytoplasmic microtubule network similar to that caused by Vincristine. In vivo, administration of compound 24 to Balb/c mice inhibited the growth of a syngenic hepatocellular carcinoma.